2160 — MicroPort CardioFlow Medtech Balance Sheet
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMid CapSucker Stock
- HK$4.20bn
- HK$2.13bn
- CNY251.03m
Annual balance sheet for MicroPort CardioFlow Medtech, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 50.7 | 110 | 613 | 2,404 | 2,076 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 4.93 | 21.3 | 26.5 | 98.6 | 52.7 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 77.3 | 184 | 720 | 2,600 | 2,272 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 34.1 | 42.8 | 68.1 | 267 | 242 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 402 | 546 | 1,112 | 3,362 | 3,001 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 115 | 388 | 1,432 | 164 | 177 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 129 | 414 | 1,457 | 266 | 248 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 273 | 132 | -345 | 3,096 | 2,754 |
| Total Liabilities & Shareholders' Equity | 402 | 546 | 1,112 | 3,362 | 3,001 |
| Total Common Shares Outstanding |